Literature DB >> 10527761

Treatment of experimental avascular necrosis of the femoral head with hyperbaric oxygen in rats: histological evaluation of the femoral heads during the early phase of the reparative process.

D Levin1, D Norman, C Zinman, L Rubinstein, E Sabo, I Misselevich, D Reis, J H Boss.   

Abstract

The healing of vascular deprivation-induced necrosis of the femoral head of rats exposed to hyperbaric oxygen was compared with that in untreated rats. The amount of necrotic bone, extent of osteoneogenesis, degree of remodeling, and changes of the articular cartilage were histologically graded on a semiquantitative scale of 0 to 3+. On the 2nd, 7th, and 21st postoperative days, there were no differences between the two groups. Newly formed appositional and intramembranous bone was more abundant and remodeling was more advanced in the femoral heads of the hyperbaric oxygen-treated than untreated rats sacrificed on the 42nd postoperative day; also there was less necrotic debris in the femoral heads of the treated rats. There were no differences in the severity of the degenerative changes of the articular cartilage of the treated and untreated rats. Exposure of rats to hyperbaric oxygen does not preserve tissue viability after all arteries supplying the femoral head are severed. Yet, resulting in an increased oxygen tension of the tissues, it seems to provide the optimal settings for reparative processes. The results suggest that hyperoxygenation-mediated relief of ischemia enhances the fibroblastic, angioblastic, osteoblastic, and osteoclastic activities such that healing of the rats' necrotic femoral heads is expedited. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10527761     DOI: 10.1006/exmp.1999.2273

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  11 in total

1.  Development of a mouse model of ischemic osteonecrosis.

Authors:  Nobuhiro Kamiya; Ryosuke Yamaguchi; Olumide Aruwajoye; Naga Suresh Adapala; Harry K W Kim
Journal:  Clin Orthop Relat Res       Date:  2015-02-10       Impact factor: 4.176

2.  CORR Insights(®): development of a mouse model of ischemic osteonecrosis.

Authors:  Bryan Samuel Margulies
Journal:  Clin Orthop Relat Res       Date:  2015-03-07       Impact factor: 4.176

3.  Vasculature deprivation-induced osteonecrosis of rats' femoral heads associated with the formation of deep surface depressions.

Authors:  J Bejar; J H Boss
Journal:  Eur J Orthop Surg Traumatol       Date:  2006-02-10

Review 4.  Experimental animal models of osteonecrosis.

Authors:  Meng Fan; Jiang Peng; Ling Qin; Shibi Lu
Journal:  Rheumatol Int       Date:  2011-02-22       Impact factor: 2.631

5.  Osteonecrosis of the femoral head: An update in year 2012.

Authors:  Anjan P Kaushik; Anusuya Das; Quanjun Cui
Journal:  World J Orthop       Date:  2012-05-18

Review 6.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

7.  Traumatic and Non-traumatic Osteonecrosis in the Femoral Head of a Rabbit Model.

Authors:  Yawon Hwang; Jinuk Park; Seok Hwa Choi; Gonhyung Kim
Journal:  Lab Anim Res       Date:  2011-06-22

Review 8.  Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.

Authors:  Jacob Bejar; Eli Peled; Jochanan H Boss
Journal:  Theor Biol Med Model       Date:  2005-07-05       Impact factor: 2.432

9.  Alendronate preserves femoral head shape and height/length ratios in an experimental rat model: A computer-assisted analysis.

Authors:  Eli Peled; Jacob Bejar; Chaim Zinman; Daniel N Reis; Jochanan H Boss; Hadar Ben-Noon; Doron Norman
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

10.  Development of a clinically relevant animal model for the talar osteonecrosis in sheep.

Authors:  Chao-Fan Yuan; Jun-Lin Wang; Yong-Quan Zhang; Xiao-Kang Li; Yi Li; Su-Hua Wu; Zhi-Yong Zhang; Zheng Guo
Journal:  Int J Med Sci       Date:  2012-10-27       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.